Source: BioPortfolio

Aquinox Pharmaceuticals: Aquinox Pharmaceuticals Inc AQXP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 23102018 Prices from USD $250

SummaryAquinox Pharmaceuticals Inc Aquinox is a pharmaceutical company that discovers and develops novel drug candidates for the treatment of inflammation inflammatory pain and blood cancers. The company's lead drug candidate include AQX1125 is a small mol...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
25-100
David J. Main's photo - President & CEO of Aquinox Pharmaceuticals

President & CEO

David J. Main

CEO Approval Rating

84/100

Read more